Evidence map›Paper›PMID 26507232›Full record

ArticlemBio2015

Toxoplasma gondii Infections Alter GABAergic Synapses and Signaling in the Central Nervous System.

Justin M Brooks, Gabriela L Carrillo, Jianmin Su, David S Lindsay, Michael A Fox, Ira J Blader

Open access · goldAbstract read
In one paragraph

Article in mBio, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 80 papers.

0numbers the graph read from it
0cells of the map it votes in
80citing papers in PubMed
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

80 citing papers in PubMed, 140 citations in OpenAlex.

  1. iScience · 2026
    Article
  2. Extracellular vesicles and circulating nucleic acids · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Beyond Latency: ChronicBiomedicines · 2025
    Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Frontiers in cellular and infection microbiology · 2025
    Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Toxoplasma-induced behavior changes - is microbial dysbiosis the missing link?Frontiers in cellular and infection microbiology · 2024
    Review
  18. mFrontiers in cell and developmental biology · 2024
    Review
  19. Ivermectin modulated cerebral γ-aminobutyric acid (GABA) and reduced the number of chronicJournal of parasitic diseases : official organ of the Indian Society for Parasitology · 2023
    Article
  20. Article

20 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Justin M BrooksDepartment of Microbiology and Immunology, SUNY at Buffalo School of Medicine, Buffalo, New York, USA.
Gabriela L CarrilloVirginia Tech Carilion Research Institute, Roanoke, Virginia, USA.
Jianmin SuVirginia Tech Carilion Research Institute, Roanoke, Virginia, USA.
David S LindsayDepartment of Biomedical Sciences and Pathobiology, Virginia Polytechnic Institute and State University, Blacksburg, Virginia, USA.
Michael A FoxVirginia Tech Carilion Research Institute, Roanoke, Virginia, USA Department of Biological Sciences, Virginia Polytechnic Institute and State University, Blacksburg, Virginia, USA mafox1@vtc.vt.edu iblader@buffalo.edu.
Ira J BladerDepartment of Microbiology and Immunology, SUNY at Buffalo School of Medicine, Buffalo, New York, USA Department of Ophthalmology, SUNY at Buffalo School of Medicine, Buffalo, New York, USA.
Virginia Tech · USUniversity at Buffalo, State University of New York · US

Funding

Toxoplasma gondii Regulation of Host GABAergic SignalingR01AI124677 · NIAID · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI BLADER, IRA J, FOX, MICHAEL A · 2016 to 2020
$2.7M
NIAID NIH HHS R01 AI124677
6 · The paper itself

Abstract

unlabelledDuring infections with the protozoan parasite Toxoplasma gondii, gamma-aminobutyric acid (GABA) is utilized as a carbon source for parasite metabolism and also to facilitate parasite dissemination by stimulating dendritic-cell motility. The best-recognized function for GABA, however, is its role in the nervous system as an inhibitory neurotransmitter that regulates the flow and timing of excitatory neurotransmission. When this pathway is altered, seizures develop. Human toxoplasmosis patients suffer from seizures, suggesting that Toxoplasma interferes with GABA signaling in the brain. Here, we show that while excitatory glutamatergic presynaptic proteins appeared normal, infection with type II ME49 Toxoplasma tissue cysts led to global changes in the distribution of glutamic acid decarboxylase 67 (GAD67), a key enzyme that catalyzes GABA synthesis in the brain. Alterations in GAD67 staining were not due to decreased expression but rather to a change from GAD67 clustering at presynaptic termini to a more diffuse localization throughout the neuropil. Consistent with a loss of GAD67 from the synaptic terminals, Toxoplasma-infected mice develop spontaneous seizures and are more susceptible to drugs that induce seizures by antagonizing GABA receptors. Interestingly, GABAergic protein mislocalization and the response to seizure-inducing drugs were observed in mice infected with type II ME49 but not type III CEP strain parasites, indicating a role for a polymorphic parasite factor(s) in regulating GABAergic synapses. Taken together, these data support a model in which seizures and other neurological complications seen in Toxoplasma-infected individuals are due, at least in part, to changes in GABAergic signaling. IMPORTANCE: Infections of the central nervous system can cause seizures. While inflammation in the brain has been proposed to initiate the onset of the seizures, relatively little is known about how inflammation impacts the structure and function of the neurons. Here we used a parasite called Toxoplasma gondii that infects the brain and showed that seizures arise due to a defect in signaling of GABA, which is the neurotransmitter primarily responsible for preventing the onset of seizures.

Indexed as

Signal TransductionAnimalsBrainCell MovementDisease Models, AnimalGABAergic Neuronsgamma-Aminobutyric AcidGlutamate DecarboxylaseHumansMiceNeuronsNeuropilSeizuresSynapsesToxoplasmaToxoplasmosis, Cerebralgamma-Aminobutyric AcidGlutamate Decarboxylase

Identifiers

PMID26507232
PMCPMC4626855
OpenAlexW2179189279

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.